PCMI
CRDF icon

Princeton Capital Management Inc’s Cardiff Oncology CRDF Stock Holding History

Princeton Capital Management Inc’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$12K Sell
237
-250
-51% -$15.6K 0.01% 69
2017
Q2 		$44K Sell
487
-10
-2% -$644 0.03% 68
2017
Q1 		$41K Sell
497
-61
-11% -$8.28K 0.03% 64
2016
Q4 		$84K Sell
558
-618
-53% -$144K 0.06% 65
2016
Q3 		$380K Buy
1,176
+214
+22% +$78K 0.25% 61
2016
Q2 		$314K Buy
+962
New +$331K 0.22% 65

Other funds holding CRDF

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Princeton Capital Management Inc's CRDF Position: Q3 2017 in Review

Princeton Capital Management Inc reduced its Cardiff Oncology (CRDF) stake by 51% in Q3 2017, selling an estimated $15.6K and leaving 237 shares worth $12K. The position accounts for 0.01% of the portfolio, ranked #69.

Princeton Capital Management Inc first reported a position in CRDF in Q2 2016 and has held it in 6 quarters since. The position peaked at $380K in Q3 2016. 47 funds tracked by Wall St. Rank hold CRDF as of Q3 2017.

  • Princeton Capital Management Inc held 237 shares of Cardiff Oncology worth $12K as of Q3 2017.
  • Princeton Capital Management Inc sold 250 Cardiff Oncology shares in Q3 2017, an estimated $15.6K.
  • Cardiff Oncology made up 0.01% of Princeton Capital Management Inc's portfolio in Q3 2017, its #69 holding.
  • Princeton Capital Management Inc first reported a position in Cardiff Oncology in Q2 2016 and has held it in 6 quarters since.
  • Princeton Capital Management Inc's Cardiff Oncology position peaked at $380K in Q3 2016.
  • 47 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2017.

Based on Princeton Capital Management Inc's 13F filing for Q3 2017, filed 3 Nov 2017.